Cargando…
Bortezomib inhibits chikungunya virus replication by interfering with viral protein synthesis
Chikungunya virus (CHIKV) is an alphavirus that causes a febrile illness accompanied by myalgia and arthralgia. Despite having re-emerged as a significant public health threat, there are no approved therapeutics or prophylactics for CHIKV infection. In this study, we explored the anti-CHIKV effects...
Autores principales: | Kaur, Parveen, Lello, Laura Sandra, Utt, Age, Dutta, Sujit Krishna, Merits, Andres, Chu, Justin Jang Hann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7286522/ https://www.ncbi.nlm.nih.gov/pubmed/32469886 http://dx.doi.org/10.1371/journal.pntd.0008336 |
Ejemplares similares
-
Versatile Trans-Replication Systems for Chikungunya Virus Allow Functional Analysis and Tagging of Every Replicase Protein
por: Utt, Age, et al.
Publicado: (2016) -
Inhibitors of Alphavirus Entry and Replication Identified with a Stable Chikungunya Replicon Cell Line and Virus-Based Assays
por: Pohjala, Leena, et al.
Publicado: (2011) -
VCP/p97 Is a Proviral Host Factor for Replication of Chikungunya Virus and Other Alphaviruses
por: Carissimo, Guillaume, et al.
Publicado: (2019) -
Chikungunya virus infectivity, RNA replication and non-structural polyprotein processing depend on the nsP2 protease’s active site cysteine residue
por: Rausalu, Kai, et al.
Publicado: (2016) -
Chikungunya virus: an update on antiviral development and challenges
por: Kaur, Parveen, et al.
Publicado: (2013)